t-cell

Documents about t-cell

• Subjects With Advanced or Metastatic Solid Tumor Malignancies#836462ClinicalTrials.gov
• Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer#148747ClinicalTrials.gov
• Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies#329527ClinicalTrials.gov
• Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia#839345ClinicalTrials.gov
• Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia#845462ClinicalTrials.gov
• Beyond sequence similarity: ML-powered identification of pHLA off-targets for TCR-mimic antibodies using high throughput binding kinetics.#9748PubMed
• Modeling and Simulation in Development and Regulatory Approval of Chimeric Antigen Receptor T-Cell Therapies: An Analysis of European Medicines Agency Centralized Procedures From 2018 to 2024.#157133NCBI PubMed Central
• Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL#162478ClinicalTrials.gov
• Mucosal T cell activation pathways are upregulated by equine herpesvirus type 1 infection#171611HAL (France)
• Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias#184921ClinicalTrials.gov
• No clear evidence of PFAS-induced immunomodulation in SARS-CoV-2-specific human T cell responses following vaccination#441182Springer Nature OA
• Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation#838192ClinicalTrials.gov
• Drugging the Medullary Thyroid Cancer Surfaceome with T Cell Engagers Targeting CEA, GFRA4 and DLL3 as Monotherapy and In Combination with Tyrosine Kinase Inhibitors#151332Unpaywall
• Integration of single-cell cis-expression quantitative trait locus and Mendelian randomization analyses identifies a Treg-specific gene for precision therapy in rheumatoid arthritis, gonarthrosis, and gouty arthritis.#320581NCBI PubMed Central
• PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy#347883HAL (France)
• Isolation of a Ubiquitous Cholesteryl Ester Spectral Signature#391579Figshare
• A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors#832218ClinicalTrials.gov
• Functional CRISPR dissection of gene networks controlling human regulatory T cell identity#780503eScholarship
• A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...#833942ClinicalTrials.gov
• Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer#825854ClinicalTrials.gov
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer#834113ClinicalTrials.gov
• Signal transducer and activator of transcription 3 (Stat3) contributes to T-cell homeostasis by regulating pro-survival Bcl-2 family genes#389942S-Space: Seoul National University
• GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults#394743ClinicalTrials.gov
• CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia#417542ClinicalTrials.gov
• Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:#802286ClinicalTrials.gov
• Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment#805034ClinicalTrials.gov
• Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant#407722ClinicalTrials.gov
• Image 2_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif#464145Figshare
• Image 1_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif#464146Figshare
• Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine#651122ClinicalTrials.gov
• Health-Related Values Discussions With Patients Receiving Allogeneic and Autologous Stem Cell Transplant and Chimeric Antigen Receptor Therapy (CAR-T): Implementation of an Early Nurse Practitioner-Led Primary Palliative Care Intervention.#472504NCBI PubMed Central
• Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment#635492IRIS
• CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia#811895ClinicalTrials.gov
• Increasing HbA1c is associated with reduced CD8⁺ T cell functionality in response to influenza virus in a TCR-dependent manner in individuals with diabetes mellitus#350260Figshare
• Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm#349954ClinicalTrials.gov
• Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications#308335HAL (France)
• IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)#366581ClinicalTrials.gov
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients#387151ClinicalTrials.gov
• Data Sheet 1_ClareV: a contrastive learning framework for context-aware TRBV representations in TCR repertoires.pdf#391597Figshare
• Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen#439890S-Space: Seoul National University
• A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia#807945ClinicalTrials.gov
• Quantifying target antigen-dependent CAR T-cell performance against AML / Saumil Atulkumar Shah, Jan Mueller, Emanuel Vogel, Michael Raatz, Steffen Boettcher, Arne Traulsen, Markus G. Manz, Philipp M. Altrock#814185Deutsche Nationalbibliothek
• Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -#825949ClinicalTrials.gov
• Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy.#140876NCBI PubMed Central
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases#217044ClinicalTrials.gov
• Immune evasion in locally advanced mismatch repair-deficient microsatellite instability-high colorectal cancer: Reduced T-cell infiltration and upregulation of epithelial IDO1 expression.#358770PubMed
• The Knowns and Unknowns of Cardiac Autoimmunity in Viral Myocarditis#440473DigitalCommons@University of Nebraska
• Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation#806322ClinicalTrials.gov
• Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells#143563ClinicalTrials.gov
• Immunomodulatory effects of acupuncture on inflammatory markers in patients with musculoskeletal pain: a systematic review of randomized controlled trials.#200327Figshare